Easterly Investment Partners’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.55M | Sell |
52,412
-3,746
| -7% | -$111K | 0.11% | 126 |
|
|
2025
Q1 | $1.68M | Hold |
56,158
| – | – | 0.14% | 119 |
|
|
2024
Q4 | $1.61M | Hold |
56,158
| – | – | 0.13% | 128 |
|
|
2024
Q3 | $2.17M | Buy |
56,158
+13,529
| +32% | +$523K | 0.17% | 108 |
|
|
2024
Q2 | $1.37M | Sell |
42,629
-7,000
| -14% | -$225K | 0.12% | 133 |
|
|
2024
Q1 | $1.93M | Sell |
49,629
-22
| -0% | -$854 | 0.15% | 123 |
|
|
2023
Q4 | $1.53M | Hold |
49,651
| – | – | 0.16% | 121 |
|
|
2023
Q3 | $1.11M | Hold |
49,651
| – | – | 0.12% | 129 |
|
|
2023
Q2 | $1.07M | Buy |
49,651
+24,622
| +98% | +$529K | 0.09% | 138 |
|
|
2023
Q1 | $600K | Buy |
25,029
+3,000
| +14% | +$72K | 0.05% | 154 |
|
|
2022
Q4 | $511K | Hold |
22,029
| – | – | 0.04% | 154 |
|
|
2022
Q3 | $353K | Hold |
22,029
| – | – | 0.03% | 160 |
|
|
2022
Q2 | $390K | Sell |
22,029
-2,000
| -8% | -$35.4K | 0.03% | 159 |
|
|
2022
Q1 | $489K | Buy |
+24,029
| New | +$489K | 0.04% | 161 |
|